Articles from Epilepsy Foundation

BOWIE, Md., July 10, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished communications and corporate affairs executive, to its National Board of Directors. Drabinsky brings extensive leadership experience in digital innovation, reputation management, and brand transformation across healthcare, technology, and global business sectors to the Foundation.

Renowned Neurologist and Epilepsy Advocate Honored for Decades of Innovation in Therapeutics, Research, and Patient Care

The Toolkit Fosters Safe and Inclusive Learning Environments for Students with Epilepsy

BOWIE, Md., April 14, 2025 (GLOBE NEWSWIRE) -- The 118 undersigned organizations – representing people living with epilepsy; caregivers and loved ones; physicians, care providers, and epilepsy centers; epilepsy researchers; and others – are united in opposition to recent actions by the Administration and Congress to cut vital federal epilepsy programs. As the fourth most common neurological condition in the world and with nearly 3.4 million Americans living with active epilepsy, we must be doing more – not less – to understand and treat epilepsy, develop cures, improve the quality of life for people with epilepsy, and increase public awareness. We urge policymakers to reverse these cuts and ensure that fundamental epilepsy public health and research programs are maintained:

The National Plan aims to support the 3.4 million people living with epilepsy in the United States through a unified approach, calling for bipartisan support.

Grzeskowiak and French set to advance research and medical care for the epilepsy community through innovation and collaboration

In addition to this year’s theme, the Epilepsy Foundation of America has an exciting new partnership announcement in honor of the awareness month

Wanda Cook Brings More Than 20 Years Finance Expertise to Support Mission

BOWIE, Md., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Epilepsy Foundation announced today it has awarded $200,000 in funding for two startups who competed in the Foundation’s 2024 Shark Tank Competition held during the Epilepsy Foundation’s Pipeline Conference in Atlanta. A $125,000 prize, comprised from both our audience voting and awarded from our sharks was given to John Terry, founder and managing director, Neuronostics to develop a digital biomarker for epilepsy diagnostic decision support with the goal of improving time to diagnosis. A $75,000 prize was awarded to Ruben Kuzniecky, M.D., co-founder, Neuroview Technology for development of a small implantable subcutaneous long-term brain monitor using electroencephalography (EEG) to record and analyze seizure activity.

The New Statements Guide the Foundation’s 2025-2028 Strategic Plan